Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 5Diarrhea 3Vulvar Neoplasms 1Vulvar Diseases 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma, Alveolar Soft Part 1Recurrence 1Rectal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Gliosarcoma 1Glioblastoma 1Exanthema 1Colitis 1Carcinoma in Situ 1

Interventions

Temozolomide 15Radiotherapy 10Radiation 8Magnetic Resonance Spectroscopy 7pembrolizumab 5Specimen Handling 5Ipilimumab 3atezolizumab 2Photons 2Nivolumab 2Biopsy 2veliparib 1selinexor 1sargramostim 1plerixafor 1peposertib 1pazopanib 1navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1montanide ISA 51 1liposomal doxorubicin 1gosha-jinki-gan 1fluorodopa F 18 1ferric pyrophosphate 1efineptakin alfa 1cemiplimab 1cabozantinib 1balstilimab 1abexinostat 1X-Rays 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Loperamide × 1 year × Clear all
NCT04216329 2026-01-23

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
11 enrolled 19 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡